Raia Drogasil S.A.
RADLY
$5.00
$0.000.00%
| Weiss Ratings | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Unrated | |||
| Risk Index | Unrated | |||
| Risk Grade | U | |||
| Reward Grade | U | |||
| Rating Factors | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Unrated | |||
| Growth Index | Unrated | |||
| Efficiency Index | Unrated | |||
| Solvency Index | Unrated | |||
| Total Return Index | Unrated | |||
| Volatility Index | Unrated | |||
| Beta / Standard Deviation | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | -- | |||
| Price History | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -- | |||
| 30-Day Total Return | -- | |||
| 60-Day Total Return | -- | |||
| 90-Day Total Return | -- | |||
| Year to Date Total Return | -- | |||
| 1-Year Total Return | -- | |||
| 2-Year Total Return | -- | |||
| 3-Year Total Return | -- | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -- | |||
| 52-Week Low % Change | -- | |||
| Price | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price (Date) | -- | |||
| Valuation | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | -- | |||
| Enterprise Value | 10.17B | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | 0.12 | |||
| Earnings Per Share Growth | -- | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -- | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | -- | |||
| Enterprise Value/EBITDA (TTM) | -- | |||
| Enterprise Value/EBIT | -- | |||
| Market Cap Category | Mid Cap | |||
| Dividends and Shares | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 1.72B | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | 44.38% | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 55 11 3769 5678 | |||
| Address | Av. Corifeu de Azevedo Marques, 3097 São Paulo, SP 05339-900 | |||
| Website | www.rd.com.br | |||
| Country | Brazil | |||
| Year Founded | 1905 | |||
| Profitability | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 6.12% | |||
| Profit Margin | 3.11% | |||
| Management Effectiveness | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 7.06% | |||
| Return on Equity | 19.30% | |||
| Income Statement | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 6.81B | |||
| Total Revenue (TTM) | 6.81B | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | 2.05B | |||
| EBITDA (TTM) | 548.16M | |||
| EBIT (TTM) | 417.30M | |||
| Net Income (TTM) | 212.06M | |||
| Net Income Avl. to Common (TTM) | 212.06M | |||
| Total Revenue Growth (Q YOY) | 20.91% | |||
| Earnings Growth (Q YOY) | 2.65% | |||
| EPS Diluted (TTM) | 0.12 | |||
| EPS Diluted Growth (Q YOY) | -2.85% | |||
| Balance Sheet | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 84.97M | |||
| Cash Per Share (Q) | $0.05 | |||
| Total Current Assets (Q) | 2.38B | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 1.24B | |||
| Current Ratio (Q) | 1.431 | |||
| Book Value Per Share (Q) | $0.72 | |||
| Total Assets (Q) | 4.14B | |||
| Total Current Liabilities (Q) | 1.67B | |||
| Total Debt (Q) | 1.46B | |||
| Total Liabilities (Q) | 2.90B | |||
| Total Common Equity (Q) | 1.23B | |||
| Cash Flow | RADLY - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -262.80M | |||
| Cash from Financing (TTM) | -97.15M | |||
| Net Change in Cash (TTM) | -2.95M | |||
| Levered Free Cash Flow (TTM) | 89.50M | |||
| Cash from Operations (TTM) | 357.01M | |||
